An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples

Briefings in Bioinformatics

Volumn 16, Issue 2, 2015, Pages 232-241

  Yadav, Vinod Kumar ^a   De, Subhajyoti ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Deconvolution; Mixed cell population; Software; Tumor purity and heterogeneity

Indexed keywords

BIOLOGY; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; NEOPLASM; PATHOLOGY; PROCEDURES; SOFTWARE; STATISTICS AND NUMERICAL DATA;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS; SOFTWARE;

EID: 84902579580     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbu002     Document Type: Article

References (56)

1. Zhao Y, Simon R. Gene expression deconvolution in clinical samples. GenomeMed 2010;2:93.
2. De S. Somatic mosaicism in healthy human tissues. Trends Genet 2011;27:217-23.
3. Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity:a looking glass for cancer? Nat RevCancer 2012;12:323-34.
4. Martins FC, De S, Almendro V, et al. Evolutionary pathways in BRCA1-associated breast tumors. Cancer Discov 2012;2:503-11.
5. Navin N, Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011;472:90-4.
6. Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. GenomeMed 2011;3:31.
7. Ding L, Raphael BJ, Chen F, et al. Advances for studying clonal evolution in cancer. Cancer Lett 2013;340:212-9.
8. Wu AR, Neff NF, Kalisky T, et al. Quantitative assessment of single-cell RNA-sequencing methods. NatMethods 2014;11:41-6.
9. Moignard V, Macaulay IC, Swiers G, et al. Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis. Nat Cell Biol 2013;15:363-72.
10. Bumgarner SL, Neuert G, Voight BF, et al. Single-cell analysis reveals that noncoding RNAs contribute to clonal heterogeneity by modulating transcription factor recruitment. Mol Cell 2012;45:470-82.
11. Ahn J, Yuan Y, Parmigiani G, et al. DeMix: deconvolution for mixed cancer transcriptomes using raw measured data. Bioinformatics 2013;29:1865-71.
12. Venet D, Pecasse F, Maenhaut C, et al. Separation of samples into their constituents using gene expression data. Bioinformatics 2001;17(Suppl. 1):S279-87.
13. Tureci O, Ding J, Hilton H, et al. Computational dissection of tissue contamination for identification of colon cancerspecific expression profiles. FASEB J 2003;17:376-85.
14. Lu P, Nakorchevskiy A, Marcotte EM. Expression deconvolution:a reinterpretation of DNA microarray data reveals dynamic changes in cell populations. ProcNatlAcad SciUSA 2003;100:10370-5.
15. Ghosh D. Mixture models for assessing differential expression in complex tissues using microarray data. Bioinformatics 2004;20:1663-9.
16. Stuart RO, Wachsman W, Berry CC, et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci USA 2004;101:615-20.
17. Lahdesmaki H, Shmulevich L, Dunmire V, et al. In silico microdissection of microarray data from heterogeneous cell populations. BMC Bioinformatics 2005;6:54.
18. Wang M, Master SR, Chodosh LA. Computational expression deconvolution in a complex mammalian organ. BMC Bioinformatics 2006;7:328.
19. Erkkila T, Lehmusvaara S, Ruusuvuori P, et al. Probabilistic analysis of gene expression measurements from heterogeneous tissues. Bioinformatics 2010;26:2571-7.
20. Shen-Orr SS, Tibshirani R, Khatri P, et al. Cell type-specific gene expression differences in complex tissues. NatMethods 2010;7:287-9.
21. Qiao W, Quon G, Csaszar E, et al. PERT: a method for expression deconvolution of human blood samples from varied microenvironmental and developmental conditions. PLoSComput Biol 2012;8:e1002838.
22. Gosink MM, Petrie HT, Tsinoremas NF. Electronically subtracting expression patterns from a mixed cell population. Bioinformatics 2007;23:3328-34.
23. Clarke J, Seo P, Clarke B. Statistical expression deconvolution from mixed tissue samples. Bioinformatics 2010;26:1043-9.
24. Roy S, Lane T, Allen C, et al. A hidden-state Markov model for cell population deconvolution. J Comput Biol 2006;13:1749-74.
25. Gaujoux R, Seoighe C. Semi-supervised Nonnegative Matrix Factorization for gene expression deconvolution: a case study. Infect Genet Evol 2012;12:913-21.
26. Repsilber D, Kern S, Telaar A, et al. Biomarker discovery in heterogeneous tissue samples - taking the insilico deconfounding approach. BMC Bioinformatics 2010;11:27.
27. Quon G, Morris Q. ISOLATE: a computational strategy for identifying the primary origin of cancers using high-throughput sequencing. Bioinformatics 2009;25:2882-9.
28. Gong T, Szustakowski JD. DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data. Bioinformatics 2013;29:1083-5.
29. Gong T, Hartmann N, Kohane IS, et al. Optimal deconvolution of transcriptional profiling data using quadratic programming with application to complex clinical blood samples. PLoS One 2011;6:e27156.
30. Li Y, Xie X. A mixture model for expression deconvolution from RNA-seq in heterogeneous tissues. BMC Bioinformatics 2013;14(Suppl. 5):S11.
31. Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 2013;4:2612.
32. Carter SL, Cibulskis K, Helman E, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012;30:413-21.
33. Jacobs S. Data analysis considerations for detecting copy number changes in formalin-fixed, paraffin-embedded tissues. Cold SpringHarb Protoc 2012;2012:1203-9.
34. Li C, Beroukhim R, Weir BA, et al. Major copy proportion analysis of tumor samples using SNP arrays. BMC Bioinformatics 2008;9:204.
35. Van Loo P, Nordgard SH, Lingjaerde OC, et al. Allelespecific copy number analysis of tumors. Proc Natl Acad Sci USA 2010;107:16910-5.
36. Su X, Zhang L, Zhang J, et al. PurityEst: estimating purity of human tumor samples using next-generation sequencing data. Bioinformatics 2012;28:2265-6.
37. Roth A, Ding J, Morin R, et al. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics 2012;28:907-13.
38. Larson NB, Fridley BL. PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data. Bioinformatics 2013;29:1888-9.
39. Oesper L, Mahmoody A, Raphael BJ. THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data. Genome Biol 2013;14:R80.
40. Andor N, Harness JV, Muller S, et al. EXPANDS: expanding ploidy and allele frequency on nested subpopulations. Bioinformatics 2014;30:50-60.
41. Gusnanto A, Wood HM, Pawitan Y, et al. Correcting for cancer genome size and tumour cell content enables better estimation of copy number alterations from next-generation sequence data. Bioinformatics 2012;28:40-7.
42. Kim S, Jeong K, Bhutani K, et al. Virmid: accurate detection of somatic mutations with sample impurity inference. Genome Biol 2013;14:R90.
43. Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013;31:213-9.
44. Larson DE, Harris CC, Chen K, et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 2012;28:311-7.
45. Saunders CT, Wong WS, Swamy S, et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 2012;28:1811-7.
46. De S, Shaknovich R, Riester M, et al. Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. PLoS Genet 2013;9:e1003137.
47. Strino F, Parisi F, Micsinai M, et al. TrAp: a tree approach for fingerprinting subclonal tumor composition. Nucleic Acids Res 2013;41:e165.
48. Landau DA, Carter SL, Stojanov P, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013;152:714-26.
49. Seo JH, Li Q, Fatima A, et al. Deconvoluting complex tissues for expression quantitative trait locus-based analyses. PhilosTrans RSoc Lond B Biol Sci 2013;368:20120363.
50. Bedard PL, Hansen AR, Ratain MJ, et al. Tumour heterogeneity in the clinic. Nature 2013;501:355-64.
51. Burrell RA, McGranahan N, Bartek J, et al. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 2013;501:338-45.
52. Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature 2013;501:328-37.
53. Lawrence MS, Stojanov P, Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013;499:214-8.
54. Kandoth C, McLellan MD, Vandin F, et al. Mutational landscape and significance across 12 major cancer types. Nature 2013;502:333-9.
55. Dewey FE, Pan S, Wheeler MT, et al. DNA sequencing:clinical applications of new DNA sequencing technologies. Circulation 2012;125:931-44.
56. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61-70.